175 related articles for article (PubMed ID: 17191049)
1. Scleromyxedema: successful treatment with thalidomide in two patients.
Amini-Adle M; Thieulent N; Dalle S; Balme B; Thomas L
Dermatology; 2007; 214(1):58-60. PubMed ID: 17191049
[TBL] [Abstract][Full Text] [Related]
2. Scleromyxedema--thalidomide therapy.
Martins A; Paiva Lopes MJ; Tavares Belo R; Rodrigues JC
J Eur Acad Dermatol Venereol; 2008 May; 22(5):622-4. PubMed ID: 18312333
[No Abstract] [Full Text] [Related]
3. Scleromyxedema, a positive effect with thalidomide.
Jacob SE; Fien S; Kerdel FA
Dermatology; 2006; 213(2):150-2. PubMed ID: 16902294
[TBL] [Abstract][Full Text] [Related]
4. Scleromyxedema without paraproteinemia.
Abarzúa AA; Giesen LF; Sandoval MO; González SB
Int J Dermatol; 2014 Aug; 53(8):971-4. PubMed ID: 24527753
[TBL] [Abstract][Full Text] [Related]
5. [Response to thalidomide in scleromyxedema].
Pascualini MF; Caballero Escuti G; Valente E; Kurpis M; Ruiz Lascano A
Medicina (B Aires); 2013; 73(3):252-4. PubMed ID: 23732202
[TBL] [Abstract][Full Text] [Related]
6. Intravenous gammaglobulin and thalidomide may be an effective therapeutic combination in refractory scleromyxedema: case report and discussion of the literature.
Efthimiou P; Blanco M
Semin Arthritis Rheum; 2008 Dec; 38(3):188-94. PubMed ID: 18221985
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of scleromyxedema with oral thalidomide.
Guarenti I; Sebastiani V; Pinto G; de Souza PR; de Almeida H
Int J Dermatol; 2013 May; 52(5):631-2. PubMed ID: 23231733
[No Abstract] [Full Text] [Related]
8. Scleromyxedema with myopathy was successfully treated by thalidomide.
Wu MY; Hong JB; Yang CC; Hu SL; Liao YH
J Eur Acad Dermatol Venereol; 2009 Feb; 23(2):189-90. PubMed ID: 18435730
[No Abstract] [Full Text] [Related]
9. Successful treatment of scleromyxedema using thalidomide.
Thyssen JP; Zachariae C; Menné T
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1396-7. PubMed ID: 17062103
[No Abstract] [Full Text] [Related]
10. Vincristine, idarubicin, dexamethasone and thalidomide in scleromyxoedema.
Laimer M; Namberger K; Massone C; Koller J; Emberger M; Pleyer L; Hintner H; Greil R
Acta Derm Venereol; 2009 Nov; 89(6):631-5. PubMed ID: 19997697
[TBL] [Abstract][Full Text] [Related]
11. Treatment of recalcitrant scleromyxedema with thalidomide in 3 patients.
Sansbury JC; Cocuroccia B; Jorizzo JL; Gubinelli E; Gisondi P; Girolomoni G
J Am Acad Dermatol; 2004 Jul; 51(1):126-31. PubMed ID: 15243538
[TBL] [Abstract][Full Text] [Related]
12. Letter to the editor.
Abarzúa A; Sandoval M; González S; Giesen L
Int J Dermatol; 2014 Sep; 53(9):1180-1. PubMed ID: 25124465
[No Abstract] [Full Text] [Related]
13. [Clinical characteristics, outcome of scleromyxoedema: a retrospective multicentre study].
Le Moigne M; Mazereeuw-Hautier J; Bonnetblanc JM; Astudillo L; D'Incan M; Bessis D; Thomas L; Debarbieux S; Ammoury A; Lamant L; Paul C
Ann Dermatol Venereol; 2010 Dec; 137(12):782-8. PubMed ID: 21134580
[TBL] [Abstract][Full Text] [Related]
14. Thalidomide and dexamethasone followed by autologous stem cell transplantation for scleromyxoedema.
Bos R; de Waal EG; Kuiper H; Hazenberg BP; Vellenga E
Rheumatology (Oxford); 2011 Oct; 50(10):1925-6. PubMed ID: 21719421
[No Abstract] [Full Text] [Related]
15. Thalidomide induces granuloma differentiation in sarcoid skin lesions associated with disease improvement.
Oliver SJ; Kikuchi T; Krueger JG; Kaplan G
Clin Immunol; 2002 Mar; 102(3):225-36. PubMed ID: 11890709
[TBL] [Abstract][Full Text] [Related]
16. Scleromyxoedema: the importance of physical examination.
Pipa S; Sá J; Mondragão A; Marinho A
BMJ Case Rep; 2018 Oct; 2018():. PubMed ID: 30317211
[No Abstract] [Full Text] [Related]
17. Thalidomide suppressed interleukin-6 but not tumor necrosis factor-alpha in volunteers with experimental endotoxemia.
Shannon E; Noveck R; Sandoval F; Kamath B; Kearney M
Transl Res; 2007 Nov; 150(5):275-80. PubMed ID: 17964516
[TBL] [Abstract][Full Text] [Related]
18. Evidence that thalidomide modifies the immune response of patients suffering from actinic prurigo.
Estrada-G I; Garibay-Escobar A; Núñez-Vázquez A; Hojyo-Tomoka T; Vega-Memije E; Cortés-Franco R; Pérez-Uribe A; Flores-Romo L; Santos-Argumedo L; Estrada-Parra S; Domínguez-Soto L
Int J Dermatol; 2004 Dec; 43(12):893-7. PubMed ID: 15569010
[TBL] [Abstract][Full Text] [Related]
19. Treatment of scleromyxedema and the dermatoneuro syndrome with intravenous immunoglobulin.
Rey JB; Luria RB
J Am Acad Dermatol; 2009 Jun; 60(6):1037-41. PubMed ID: 19249127
[TBL] [Abstract][Full Text] [Related]
20. Scleromyxedema.
Cokonis Georgakis CD; Falasca G; Georgakis A; Heymann WR
Clin Dermatol; 2006; 24(6):493-7. PubMed ID: 17113967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
